Table 3.
Student feedback from end-of-course evaluations (AY 15–20)
| Very dissatisfied (1) | Dissatisfied (2) | Neutral (3) | Satisfied (4) | Very satisfied (5) | Mean (SD)b overall | |
|---|---|---|---|---|---|---|
| Overall learning experience (n = 69) | 0 (0.0%)a | 0 (0.0%) | 5 (7.2%) | 25 (36.2%) | 39 (56.5%) | 4.5 (0.6) |
| Effectiveness of course leadership (n = 69) | 0 (0.0%) | 1 (1.4%) | 3 (4.3%) | 20 (29.0%) | 45 (65.2%) | 4.6 (0.7) |
| Mix of learning activities to support objectives (n = 69) | 0 (0.0%) | 2 (2.9%) | 3 (4.3%) | 26 (37.7%) | 38 (55.1%) | 4.4 (0.7) |
| Strongly disagree (1) | Disagree (2) | Neutral (3) | Agree (4) | Strongly agree (5) | Mean (SD) | |
| Foundational science learning was embedded in the clinical experiences (n = 69) | 0 (0.0%) | 1 (1.4%) | 5 (7.2%) | 29 (42.0%) | 36 (49.3%) | 4.4 (0.7%) |
| Clinical relevance was provided during non-clinical foundational science learning activities (n = 69) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 33 (47.8%) | 36 (52.2%) | 4.5 (0.5%) |
| Participation in this course advanced my foundational science knowledge in this area (n = 69)c | 1 (1.8%) | 0 (0.0%) | 1 (1.8%) | 26 (37.7%) | 41 (59.4%) | 4.5 (0.7%) |
| I anticipate using the foundational science knowledge I acquired in this course in my future clinical training and practice (n = 69 | 0 (0.0%) | 2 (2.9%) | 4 (5.8%) | 32 (46.4%) | 31 (44.9%) | 4.3 (0.7) |
| I would recommend this course to my peers (n = 69) | 0 (0.0%) | 1 (1.4%) | 5 (7.2%) | 29 (42.0%) | 34 (49.3%) | 4.4 (0.7) |
| Participation in patient encounters during the clinical experiences was positive and reinforced the applicability of the foundational science learned during other class activities (n = 65) | 0 (0.0%) | 0 (0.0%) | 2 (3.1%) | 27 (41.5%) | 36 (55.4%) | 4.5 (0.6) |
SD standard deviation
aNumber of responses (percent)
bIn AY 15–16, the wording for this question was, “Participation in this course helped me learn relevant foundational sciences.”